Products being lined up. Revenue streams secured. Sister company go current. RSHNs financials coming soon. Monster squeeze on the way causing some to chase the choo choo...
"With funding, our Spectrum formulations have the capacity to improve the lives of those who suffer from Autistic Spectrum Disorder, an issue influencing, at least marginally in some cases, one out of every 59 individuals."